Health Catalyst, Inc. (HCAT)

NASDAQ: HCAT · IEX Real-Time Price · USD
7.53
+0.09 (1.21%)
At close: Mar 28, 2024, 4:00 PM
7.39
-0.14 (-1.86%)
After-hours: Mar 28, 2024, 7:21 PM EDT

Company Description

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States.

It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.

It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies.

The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017.

Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Health Catalyst, Inc.
Health Catalyst logo
Country United States
Founded 2008
IPO Date Jul 25, 2019
Industry Health Information Services
Sector Healthcare
Employees 1,300
CEO Daniel D. Burton

Contact Details

Address:
10897 South River Front Parkway, #300
South Jordan, Utah 84095
United States
Phone 801-708-6800
Website healthcatalyst.com

Stock Details

Ticker Symbol HCAT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $26.00
CIK Code 0001636422
CUSIP Number 42225T107
ISIN Number US42225T1079
Employer ID 45-3337483
SIC Code 7370

Key Executives

Name Position
Daniel D. Burton Chief Executive Officer and Director
Daniel H. Orenstein Senior Advisor
Bryan Truman Hunt Senior Advisor
Kevin Freeman Chief Commercial Officer
Jason Alger Chief Financial Officer and Chief Accounting Officer
Daniel LeSueur Chief Operating Officer
Dave Ross Chief Technology Officer
Adam Brown Senior Vice President of Investor Relations and Financial Planning and Analysis
Benjamin Landry General Counsel and Secretary of the Board
Tarah Neujahr Bryan Chief Marketing and Communications Officer

Latest SEC Filings

Date Type Title
Mar 15, 2024 144 Filing
Mar 5, 2024 144 Filing
Mar 1, 2024 144 Filing
Mar 1, 2024 144 Filing
Mar 1, 2024 144 Filing
Mar 1, 2024 144 Filing
Mar 1, 2024 144 Filing
Mar 1, 2024 144 Filing
Mar 1, 2024 144 Filing
Feb 23, 2024 S-8 Securities to be offered to employees in employee benefit plans